CN103721151A - Formulation for curing diabetes - Google Patents
Formulation for curing diabetes Download PDFInfo
- Publication number
- CN103721151A CN103721151A CN201210392120.1A CN201210392120A CN103721151A CN 103721151 A CN103721151 A CN 103721151A CN 201210392120 A CN201210392120 A CN 201210392120A CN 103721151 A CN103721151 A CN 103721151A
- Authority
- CN
- China
- Prior art keywords
- radix
- percent
- fructus
- scrophulariae
- rhizoma atractylodis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a formulation for curing the diabetes. The formulation is prepared from the following ingredients in mass percent: 4 percent of rhizome of rehmannia, 4 percent of prepared rhizome of rehmannia, 5 percent of radix trichosanthis, 5 percent of ginseng, 5 percent of radix scrophulariae, 4 percent of codonopsis pilosula, 4 percent of radix scrophulariae, 5 percent of American ginseng, 5 percent of astragalus membranaceus, 6 percent of rhizoma atractylodis, pumpkin powder, 8 percent of barbary wolfberry fruit, 7 percent of cortex lycii radicis, 6 percent of fruit of Chinese magnoliavine, 6 percent of mulberry, 5 percent of glossy ganoderma, 5 percent of fructus alpiniae oxyphyllae, 4 percent of bighead atractylodes rhizome, 3 percent of lonicera japonica, 6 percent of bitter gourd and 3 percent of poria cocos.
Description
Technical field
The present invention relates to a kind of formula, specifically relates to a kind of formula for the treatment of diabetes.
Background technology
Diabetes are regarded as the commonly encountered diseases of middle-aged and elderly people, are also a kind of frequently-occurring diseases.In order to treat diabetes, there are various medical procedure, somewhat expensive, but not very desirable.Fundamentally treating diabetes also needs have Chinese medicine to treat, by Chinese medicine supplement the required essence of people, gas, god treats diabetes from root.
The patent for the treatment of at home at present diabetes has a lot, has by insulin injection and realizes hypoinsulinism, cost too expensive; Have and treat by dietetic therapy, effect is not very remarkable.
Summary of the invention
The object of the invention is to have overcome deficiency of the prior art, a kind of formula for the treatment of diabetes is provided.
In order to solve the problems of the technologies described above, the present invention is achieved through the following technical solutions:
This formula consists of the following composition: the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Trichosanthis, Radix Ginseng, Radix Scrophulariae, Radix Codonopsis, Radix Scrophulariae, Radix Panacis Quinquefolii, the Radix Astragali, Rhizoma Atractylodis, Fructus Cucurbitae moschatae powder, Fructus Lycii, Cortex Lycii, Fructus Schisandrae Chinensis, Fructus Mori, Ganoderma, Fructus Alpiniae Oxyphyllae, the Rhizoma Atractylodis Macrocephalae, Flos Lonicerae, Fructus Momordicae charantiae, Poria.
The constituent of this formula (being calculated in mass percent number): the Radix Rehmanniae 4%, Radix Rehmanniae Preparata 4%, Radix Trichosanthis 5%, Radix Ginseng 5%, Radix Scrophulariae 5%, Radix Codonopsis 4%, Radix Scrophulariae 4%, Radix Panacis Quinquefolii 5%, the Radix Astragali 5%, Rhizoma Atractylodis 6%, Fructus Lycii 8%, Cortex Lycii 7%, Fructus Schisandrae Chinensis 6%, Fructus Mori 6%, Ganoderma 5%, Fructus Alpiniae Oxyphyllae 5%, the Rhizoma Atractylodis Macrocephalae 4%, Flos Lonicerae 3%, Fructus Momordicae charantiae 6%, Poria 3%.
Radix Ginseng: treatment diabetes not only can be improved general symptom as weak, thirsty, weak etc., and can reduce blood glucose and glucose in urine.Be applicable to light, middle diabetes mellitus type, Chinese medical discrimination is suffered from a deficiency of the kidney, gas deficiency of YIN person better efficacy, and the deficiency of YIN scorching person should not take.
The Radix Astragali: there is myocardial contraction, the diastole coronary vasodilator of reinforcement, reduce blood pressure, protect hepatocyte, reduce blood glucose effect.
The Radix Rehmanniae, Radix Rehmanniae Preparata: there is the effect of the blood glucose of reduction, and can suppress experimental hyperglycemia.
Radix Scrophulariae: there is blood pressure lowering, reduce blood glucose effect.
Fructus Lycii: there is blood glucose, blood pressure lowering and the lipotropy of reduction.
Cortex Lycii: pharmacological research has obvious blood pressure lowering and reduces blood glucose effect.
The manufacture method of this formula: by Radix Ginseng, Radix Scrophulariae, Radix Codonopsis, Radix Scrophulariae, Radix Panacis Quinquefolii, the Radix Astragali,
Cortex Lycii, Fructus Schisandrae Chinensis, Fructus Mori, Ganoderma are put into decocting medicine pot temperature fire and decoct 4 hours, add other Chinese medicine, fried 2 hours of temperature fire, and the mixing ratio of medicine and water is 1:4.Boiled rear taking-up liquid drinkable.
Compared with prior art, the invention has the beneficial effects as follows:
The undeclared part that relates in the present invention is same as the prior art or adopt prior art to be realized.
Claims (4)
1. a formula for the treatment of diabetes, comprise the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Trichosanthis, Radix Ginseng, Radix Scrophulariae, Radix Codonopsis, Radix Scrophulariae, Radix Panacis Quinquefolii, the Radix Astragali, Rhizoma Atractylodis, Fructus Cucurbitae moschatae powder, Fructus Lycii, Cortex Lycii, Fructus Schisandrae Chinensis, Fructus Mori, Ganoderma, Fructus Alpiniae Oxyphyllae, the Rhizoma Atractylodis Macrocephalae, Flos Lonicerae, Fructus Momordicae charantiae, Poria, it is characterized in that: described constituent; Described composition mixing ratio; Described manufacture method.
2. constituent according to claim 1, is characterized in that: described constituent is comprised of the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Trichosanthis, Radix Ginseng, Radix Scrophulariae, Radix Codonopsis, Radix Scrophulariae, Radix Panacis Quinquefolii, the Radix Astragali, Rhizoma Atractylodis, Fructus Cucurbitae moschatae powder, Fructus Lycii, Cortex Lycii, Fructus Schisandrae Chinensis, Fructus Mori, Ganoderma, Fructus Alpiniae Oxyphyllae, the Rhizoma Atractylodis Macrocephalae, Flos Lonicerae, Fructus Momordicae charantiae, Poria.
3. mixed proportion according to claim 1, is characterized in that: the mixed proportion of described this formula (being calculated in mass percent number): the Radix Rehmanniae 4%, Radix Rehmanniae Preparata 4%, Radix Trichosanthis 5%, Radix Ginseng 5%, Radix Scrophulariae 5%, Radix Codonopsis 4%, Radix Scrophulariae 4%, Radix Panacis Quinquefolii 5%, the Radix Astragali 5%, Rhizoma Atractylodis 6%, Fructus Lycii 8%, Cortex Lycii 7%, Fructus Schisandrae Chinensis 6%, Fructus Mori 6%, Ganoderma 5%, Fructus Alpiniae Oxyphyllae 5%, the Rhizoma Atractylodis Macrocephalae 4%, Flos Lonicerae 3%, Fructus Momordicae charantiae 6%, Poria 3%.
4. manufacture method according to claim 1, is characterized in that: described manufacture method for by Radix Ginseng, Radix Scrophulariae, Radix Codonopsis, Radix Scrophulariae, Radix Panacis Quinquefolii, the Radix Astragali,
Cortex Lycii, Fructus Schisandrae Chinensis, Fructus Mori, Ganoderma are put into decocting medicine pot temperature fire and decoct 4 hours, add other Chinese medicine, fried 2 hours of temperature fire, and the mixing ratio of medicine and water is 1:4, has boiled rear taking-up liquid drinkable.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210392120.1A CN103721151A (en) | 2012-10-16 | 2012-10-16 | Formulation for curing diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210392120.1A CN103721151A (en) | 2012-10-16 | 2012-10-16 | Formulation for curing diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103721151A true CN103721151A (en) | 2014-04-16 |
Family
ID=50445612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210392120.1A Pending CN103721151A (en) | 2012-10-16 | 2012-10-16 | Formulation for curing diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103721151A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103976433A (en) * | 2014-04-17 | 2014-08-13 | 五河县鲲鹏食品饮料有限公司 | Magnolia officinalis blood sugar-reduction health beverage and preparation method thereof |
-
2012
- 2012-10-16 CN CN201210392120.1A patent/CN103721151A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103976433A (en) * | 2014-04-17 | 2014-08-13 | 五河县鲲鹏食品饮料有限公司 | Magnolia officinalis blood sugar-reduction health beverage and preparation method thereof |
| CN103976433B (en) * | 2014-04-17 | 2015-10-28 | 五河县鲲鹏食品饮料有限公司 | A kind of bark of official magnolia blood sugar reducing health beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100420472C (en) | Diabetes treating medicine | |
| CN102512587B (en) | Decoction for treating viral myocarditis | |
| CN102258710B (en) | Traditional Chinese medicine composition for treating type II diabetes | |
| CN1891279A (en) | Capsule for treating cardio-cerebrovasular disease | |
| CN105412615A (en) | Traditional Chinese medicine composition for treating diabetes caused by deficiency of qi and yin | |
| CN101366908A (en) | Traditional Chinese medicine for treating diabetes | |
| CN100404066C (en) | Chinese medicine for treating diabetes mellitus and its preparation | |
| CN106692780B (en) | Composition for preventing and relieving diabetes and complications thereof | |
| CN104352942A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN101574471A (en) | Medicament for treating diabetes and preparation method thereof | |
| CN102895611A (en) | Prescription of traditional Chinese medicine used for treating hypothyroidism caused by spleen-kidney yang deficiency | |
| CN103721151A (en) | Formulation for curing diabetes | |
| CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
| CN106581345A (en) | Stomach disease treating medicine and production method thereof | |
| CN103169865B (en) | Traditional Chinese medicine oral syrup for treating diabetes (diabetes mellitus) | |
| CN102961592B (en) | Traditional Chinese medicine composition for treating type II diabetes | |
| CN106492005A (en) | A kind of Chinese medicinal formulae for treating diabetes | |
| CN106983816A (en) | A kind of medicine for merging chronic heart failure for maintenance hemodialysis patient and preparation method thereof | |
| CN101584835A (en) | Chinese medicament for treating irregular menstruation | |
| CN1742835A (en) | Xiaotongchui medicated liquor | |
| CN104958435A (en) | Blood-replenishing oral liquid | |
| CN103463237A (en) | Traditional Chinese medicine for clearing liver heat and stabilizing blood pressure | |
| CN105663668A (en) | Traditional Chinese medicine for treating diabetic complications and preparation method thereof | |
| CN103784721A (en) | Medicine composition for treating aphthae of horses | |
| CN115919969A (en) | Astragalus and codonopsis composition for treating hypertension and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140416 |